Predictive Biosciences Raises $25 Million
Predictive Biosciences, a Lexington, Mass.-based developer of intervention diagnostic assays for cancer management, has raised $25 million in Series C funding. ProQuest Investments led the round, and was joined by return backers Flybridge Capital Partners, Highland Capital Partners, Kaiser Permanente Ventures and New Enterprise Associates. The company previously raised $32 million.
16 June 2010•3 mins read
